nodes	percent_of_prediction	percent_of_DWPC	metapath
Sotalol—Urogenital disorder—Sorafenib—liver cancer	0.0928	0.0935	CcSEcCtD
Sotalol—Tachyarrhythmia—Epirubicin—liver cancer	0.0308	0.031	CcSEcCtD
Sotalol—Tachyarrhythmia—Doxorubicin—liver cancer	0.0285	0.0287	CcSEcCtD
Sotalol—Cardiogenic shock—Epirubicin—liver cancer	0.0269	0.0271	CcSEcCtD
Sotalol—Cardiogenic shock—Doxorubicin—liver cancer	0.0248	0.025	CcSEcCtD
Sotalol—Alopecia reversible—Epirubicin—liver cancer	0.0248	0.025	CcSEcCtD
Sotalol—Respiratory distress—Sorafenib—liver cancer	0.024	0.0242	CcSEcCtD
Sotalol—Alopecia reversible—Doxorubicin—liver cancer	0.0229	0.0231	CcSEcCtD
Sotalol—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0209	0.0211	CcSEcCtD
Sotalol—Peripheral vascular disorder—Epirubicin—liver cancer	0.0115	0.0116	CcSEcCtD
Sotalol—Cardiac failure—Sorafenib—liver cancer	0.0113	0.0114	CcSEcCtD
Sotalol—Pain in extremity—Sorafenib—liver cancer	0.0111	0.0111	CcSEcCtD
Sotalol—Peripheral vascular disorder—Doxorubicin—liver cancer	0.0106	0.0107	CcSEcCtD
Sotalol—Mood swings—Sorafenib—liver cancer	0.0105	0.0105	CcSEcCtD
Sotalol—Acute coronary syndrome—Sorafenib—liver cancer	0.0084	0.00846	CcSEcCtD
Sotalol—Myocardial infarction—Sorafenib—liver cancer	0.00835	0.00841	CcSEcCtD
Sotalol—Neuropathy peripheral—Sorafenib—liver cancer	0.00835	0.00841	CcSEcCtD
Sotalol—Paralysis—Epirubicin—liver cancer	0.0081	0.00816	CcSEcCtD
Sotalol—Hyperlipidaemia—Epirubicin—liver cancer	0.00781	0.00787	CcSEcCtD
Sotalol—Haemoglobin—Sorafenib—liver cancer	0.00769	0.00774	CcSEcCtD
Sotalol—Haemorrhage—Sorafenib—liver cancer	0.00765	0.0077	CcSEcCtD
Sotalol—Paralysis—Doxorubicin—liver cancer	0.00749	0.00755	CcSEcCtD
Sotalol—Hyperlipidaemia—Doxorubicin—liver cancer	0.00722	0.00728	CcSEcCtD
Sotalol—Angiopathy—Sorafenib—liver cancer	0.00694	0.00699	CcSEcCtD
Sotalol—Arrhythmia—Sorafenib—liver cancer	0.00683	0.00688	CcSEcCtD
Sotalol—Alopecia—Sorafenib—liver cancer	0.00676	0.00681	CcSEcCtD
Sotalol—Dysgeusia—Sorafenib—liver cancer	0.00652	0.00657	CcSEcCtD
Sotalol—Cardiovascular disorder—Epirubicin—liver cancer	0.0064	0.00645	CcSEcCtD
Sotalol—Vasodilation procedure—Epirubicin—liver cancer	0.0064	0.00645	CcSEcCtD
Sotalol—Vasodilation—Epirubicin—liver cancer	0.0064	0.00645	CcSEcCtD
Sotalol—Muscle spasms—Sorafenib—liver cancer	0.0064	0.00645	CcSEcCtD
Sotalol—Ventricular extrasystoles—Epirubicin—liver cancer	0.00623	0.00628	CcSEcCtD
Sotalol—Syncope—Sorafenib—liver cancer	0.00597	0.00601	CcSEcCtD
Sotalol—Leukopenia—Sorafenib—liver cancer	0.00596	0.006	CcSEcCtD
Sotalol—Vasodilation procedure—Doxorubicin—liver cancer	0.00593	0.00597	CcSEcCtD
Sotalol—Vasodilation—Doxorubicin—liver cancer	0.00593	0.00597	CcSEcCtD
Sotalol—Cardiovascular disorder—Doxorubicin—liver cancer	0.00593	0.00597	CcSEcCtD
Sotalol—Loss of consciousness—Sorafenib—liver cancer	0.00585	0.00589	CcSEcCtD
Sotalol—Cough—Sorafenib—liver cancer	0.00581	0.00585	CcSEcCtD
Sotalol—Atrioventricular block—Epirubicin—liver cancer	0.0058	0.00585	CcSEcCtD
Sotalol—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00577	0.00581	CcSEcCtD
Sotalol—Hypertension—Sorafenib—liver cancer	0.00575	0.00579	CcSEcCtD
Sotalol—Coordination abnormal—Epirubicin—liver cancer	0.00573	0.00577	CcSEcCtD
Sotalol—Myalgia—Sorafenib—liver cancer	0.00567	0.00571	CcSEcCtD
Sotalol—Ventricular tachycardia—Epirubicin—liver cancer	0.00563	0.00567	CcSEcCtD
Sotalol—Infection—Sorafenib—liver cancer	0.0054	0.00544	CcSEcCtD
Sotalol—Atrioventricular block—Doxorubicin—liver cancer	0.00537	0.00541	CcSEcCtD
Sotalol—Shock—Sorafenib—liver cancer	0.00535	0.00539	CcSEcCtD
Sotalol—Thrombocytopenia—Sorafenib—liver cancer	0.00532	0.00536	CcSEcCtD
Sotalol—Coordination abnormal—Doxorubicin—liver cancer	0.0053	0.00534	CcSEcCtD
Sotalol—Ventricular tachycardia—Doxorubicin—liver cancer	0.00521	0.00525	CcSEcCtD
Sotalol—Pulmonary oedema—Epirubicin—liver cancer	0.00501	0.00505	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00495	0.00499	CcSEcCtD
Sotalol—Dyspnoea—Sorafenib—liver cancer	0.00484	0.00488	CcSEcCtD
Sotalol—Dyspepsia—Sorafenib—liver cancer	0.00478	0.00482	CcSEcCtD
Sotalol—Decreased appetite—Sorafenib—liver cancer	0.00472	0.00476	CcSEcCtD
Sotalol—Fatigue—Sorafenib—liver cancer	0.00468	0.00472	CcSEcCtD
Sotalol—Pain—Sorafenib—liver cancer	0.00465	0.00468	CcSEcCtD
Sotalol—Pulmonary oedema—Doxorubicin—liver cancer	0.00463	0.00467	CcSEcCtD
Sotalol—Vascular purpura—Epirubicin—liver cancer	0.00457	0.0046	CcSEcCtD
Sotalol—Gastrointestinal pain—Sorafenib—liver cancer	0.00444	0.00448	CcSEcCtD
Sotalol—Body temperature increased—Sorafenib—liver cancer	0.00429	0.00433	CcSEcCtD
Sotalol—Abdominal pain—Sorafenib—liver cancer	0.00429	0.00433	CcSEcCtD
Sotalol—Purpura—Epirubicin—liver cancer	0.00424	0.00427	CcSEcCtD
Sotalol—Vascular purpura—Doxorubicin—liver cancer	0.00423	0.00426	CcSEcCtD
Sotalol—Cardiac failure—Epirubicin—liver cancer	0.00419	0.00422	CcSEcCtD
Sotalol—Cerebrovascular accident—Epirubicin—liver cancer	0.00417	0.0042	CcSEcCtD
Sotalol—Lethargy—Epirubicin—liver cancer	0.00417	0.0042	CcSEcCtD
Sotalol—Pain in extremity—Epirubicin—liver cancer	0.00409	0.00412	CcSEcCtD
Sotalol—Affect lability—Epirubicin—liver cancer	0.00402	0.00405	CcSEcCtD
Sotalol—Purpura—Doxorubicin—liver cancer	0.00392	0.00395	CcSEcCtD
Sotalol—Asthenia—Sorafenib—liver cancer	0.0039	0.00393	CcSEcCtD
Sotalol—Cardiac failure—Doxorubicin—liver cancer	0.00387	0.0039	CcSEcCtD
Sotalol—Mood swings—Epirubicin—liver cancer	0.00387	0.0039	CcSEcCtD
Sotalol—Lethargy—Doxorubicin—liver cancer	0.00386	0.00389	CcSEcCtD
Sotalol—Cerebrovascular accident—Doxorubicin—liver cancer	0.00386	0.00389	CcSEcCtD
Sotalol—Pruritus—Sorafenib—liver cancer	0.00384	0.00387	CcSEcCtD
Sotalol—Pain in extremity—Doxorubicin—liver cancer	0.00378	0.00381	CcSEcCtD
Sotalol—Affect lability—Doxorubicin—liver cancer	0.00372	0.00375	CcSEcCtD
Sotalol—Diarrhoea—Sorafenib—liver cancer	0.00372	0.00374	CcSEcCtD
Sotalol—Dizziness—Sorafenib—liver cancer	0.00359	0.00362	CcSEcCtD
Sotalol—Mood swings—Doxorubicin—liver cancer	0.00358	0.00361	CcSEcCtD
Sotalol—Abdominal distension—Epirubicin—liver cancer	0.00355	0.00358	CcSEcCtD
Sotalol—Asthma—Epirubicin—liver cancer	0.00353	0.00356	CcSEcCtD
Sotalol—Influenza—Epirubicin—liver cancer	0.00353	0.00356	CcSEcCtD
Sotalol—Eosinophilia—Epirubicin—liver cancer	0.0035	0.00352	CcSEcCtD
Sotalol—Vomiting—Sorafenib—liver cancer	0.00345	0.00348	CcSEcCtD
Sotalol—Angina pectoris—Epirubicin—liver cancer	0.00344	0.00347	CcSEcCtD
Sotalol—Rash—Sorafenib—liver cancer	0.00343	0.00345	CcSEcCtD
Sotalol—Dermatitis—Sorafenib—liver cancer	0.00342	0.00345	CcSEcCtD
Sotalol—Headache—Sorafenib—liver cancer	0.0034	0.00343	CcSEcCtD
Sotalol—Ibuprofen—PPARG—liver cancer	0.00335	0.452	CrCbGaD
Sotalol—Abdominal distension—Doxorubicin—liver cancer	0.00329	0.00331	CcSEcCtD
Sotalol—Upper respiratory tract infection—Epirubicin—liver cancer	0.00328	0.00331	CcSEcCtD
Sotalol—Asthma—Doxorubicin—liver cancer	0.00327	0.00329	CcSEcCtD
Sotalol—Influenza—Doxorubicin—liver cancer	0.00327	0.00329	CcSEcCtD
Sotalol—Eosinophilia—Doxorubicin—liver cancer	0.00323	0.00326	CcSEcCtD
Sotalol—Nausea—Sorafenib—liver cancer	0.00323	0.00325	CcSEcCtD
Sotalol—Photosensitivity reaction—Epirubicin—liver cancer	0.00322	0.00325	CcSEcCtD
Sotalol—Hyperglycaemia—Epirubicin—liver cancer	0.00318	0.00321	CcSEcCtD
Sotalol—Angina pectoris—Doxorubicin—liver cancer	0.00318	0.00321	CcSEcCtD
Sotalol—Drowsiness—Epirubicin—liver cancer	0.00315	0.00317	CcSEcCtD
Sotalol—Neuropathy peripheral—Epirubicin—liver cancer	0.00309	0.00311	CcSEcCtD
Sotalol—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00304	0.00306	CcSEcCtD
Sotalol—Photosensitivity reaction—Doxorubicin—liver cancer	0.00298	0.003	CcSEcCtD
Sotalol—Hyperglycaemia—Doxorubicin—liver cancer	0.00295	0.00297	CcSEcCtD
Sotalol—Agranulocytosis—Epirubicin—liver cancer	0.00294	0.00296	CcSEcCtD
Sotalol—Drowsiness—Doxorubicin—liver cancer	0.00291	0.00293	CcSEcCtD
Sotalol—Bradycardia—Epirubicin—liver cancer	0.00288	0.0029	CcSEcCtD
Sotalol—Neuropathy peripheral—Doxorubicin—liver cancer	0.00286	0.00288	CcSEcCtD
Sotalol—Haemoglobin—Epirubicin—liver cancer	0.00284	0.00286	CcSEcCtD
Sotalol—Haemorrhage—Epirubicin—liver cancer	0.00283	0.00285	CcSEcCtD
Sotalol—Isoprenaline—CYP1A1—liver cancer	0.0028	0.378	CrCbGaD
Sotalol—Visual impairment—Epirubicin—liver cancer	0.00272	0.00274	CcSEcCtD
Sotalol—Agranulocytosis—Doxorubicin—liver cancer	0.00272	0.00274	CcSEcCtD
Sotalol—Bradycardia—Doxorubicin—liver cancer	0.00266	0.00268	CcSEcCtD
Sotalol—Haemoglobin—Doxorubicin—liver cancer	0.00263	0.00265	CcSEcCtD
Sotalol—Haemorrhage—Doxorubicin—liver cancer	0.00261	0.00263	CcSEcCtD
Sotalol—Angiopathy—Epirubicin—liver cancer	0.00256	0.00258	CcSEcCtD
Sotalol—Arrhythmia—Epirubicin—liver cancer	0.00252	0.00254	CcSEcCtD
Sotalol—Visual impairment—Doxorubicin—liver cancer	0.00252	0.00254	CcSEcCtD
Sotalol—Alopecia—Epirubicin—liver cancer	0.0025	0.00252	CcSEcCtD
Sotalol—Flatulence—Epirubicin—liver cancer	0.00242	0.00244	CcSEcCtD
Sotalol—Dysgeusia—Epirubicin—liver cancer	0.00241	0.00243	CcSEcCtD
Sotalol—Back pain—Epirubicin—liver cancer	0.00238	0.0024	CcSEcCtD
Sotalol—Angiopathy—Doxorubicin—liver cancer	0.00237	0.00239	CcSEcCtD
Sotalol—Muscle spasms—Epirubicin—liver cancer	0.00237	0.00238	CcSEcCtD
Sotalol—Arrhythmia—Doxorubicin—liver cancer	0.00234	0.00235	CcSEcCtD
Sotalol—Vision blurred—Epirubicin—liver cancer	0.00232	0.00234	CcSEcCtD
Sotalol—Alopecia—Doxorubicin—liver cancer	0.00231	0.00233	CcSEcCtD
Sotalol—Flatulence—Doxorubicin—liver cancer	0.00224	0.00226	CcSEcCtD
Sotalol—Dysgeusia—Doxorubicin—liver cancer	0.00223	0.00225	CcSEcCtD
Sotalol—Vertigo—Epirubicin—liver cancer	0.00221	0.00223	CcSEcCtD
Sotalol—Syncope—Epirubicin—liver cancer	0.00221	0.00222	CcSEcCtD
Sotalol—Leukopenia—Epirubicin—liver cancer	0.0022	0.00222	CcSEcCtD
Sotalol—Back pain—Doxorubicin—liver cancer	0.0022	0.00222	CcSEcCtD
Sotalol—Muscle spasms—Doxorubicin—liver cancer	0.00219	0.0022	CcSEcCtD
Sotalol—Palpitations—Epirubicin—liver cancer	0.00217	0.00219	CcSEcCtD
Sotalol—Loss of consciousness—Epirubicin—liver cancer	0.00216	0.00218	CcSEcCtD
Sotalol—Cough—Epirubicin—liver cancer	0.00215	0.00216	CcSEcCtD
Sotalol—Vision blurred—Doxorubicin—liver cancer	0.00215	0.00216	CcSEcCtD
Sotalol—Hypertension—Epirubicin—liver cancer	0.00212	0.00214	CcSEcCtD
Sotalol—Chest pain—Epirubicin—liver cancer	0.00209	0.00211	CcSEcCtD
Sotalol—Myalgia—Epirubicin—liver cancer	0.00209	0.00211	CcSEcCtD
Sotalol—Anxiety—Epirubicin—liver cancer	0.00209	0.0021	CcSEcCtD
Sotalol—Vertigo—Doxorubicin—liver cancer	0.00205	0.00206	CcSEcCtD
Sotalol—Syncope—Doxorubicin—liver cancer	0.00204	0.00206	CcSEcCtD
Sotalol—Leukopenia—Doxorubicin—liver cancer	0.00204	0.00205	CcSEcCtD
Sotalol—Palpitations—Doxorubicin—liver cancer	0.00201	0.00203	CcSEcCtD
Sotalol—Oedema—Epirubicin—liver cancer	0.00201	0.00202	CcSEcCtD
Sotalol—Loss of consciousness—Doxorubicin—liver cancer	0.002	0.00202	CcSEcCtD
Sotalol—Infection—Epirubicin—liver cancer	0.00199	0.00201	CcSEcCtD
Sotalol—Cough—Doxorubicin—liver cancer	0.00199	0.002	CcSEcCtD
Sotalol—Shock—Epirubicin—liver cancer	0.00198	0.00199	CcSEcCtD
Sotalol—Thrombocytopenia—Epirubicin—liver cancer	0.00197	0.00198	CcSEcCtD
Sotalol—Hypertension—Doxorubicin—liver cancer	0.00197	0.00198	CcSEcCtD
Sotalol—Hyperhidrosis—Epirubicin—liver cancer	0.00194	0.00196	CcSEcCtD
Sotalol—Myalgia—Doxorubicin—liver cancer	0.00194	0.00195	CcSEcCtD
Sotalol—Chest pain—Doxorubicin—liver cancer	0.00194	0.00195	CcSEcCtD
Sotalol—Anxiety—Doxorubicin—liver cancer	0.00193	0.00195	CcSEcCtD
Sotalol—Hypotension—Epirubicin—liver cancer	0.00188	0.00189	CcSEcCtD
Sotalol—Oedema—Doxorubicin—liver cancer	0.00186	0.00187	CcSEcCtD
Sotalol—Infection—Doxorubicin—liver cancer	0.00185	0.00186	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00183	0.00184	CcSEcCtD
Sotalol—Shock—Doxorubicin—liver cancer	0.00183	0.00184	CcSEcCtD
Sotalol—Thrombocytopenia—Doxorubicin—liver cancer	0.00182	0.00183	CcSEcCtD
Sotalol—Insomnia—Epirubicin—liver cancer	0.00182	0.00183	CcSEcCtD
Sotalol—Paraesthesia—Epirubicin—liver cancer	0.0018	0.00182	CcSEcCtD
Sotalol—Hyperhidrosis—Doxorubicin—liver cancer	0.0018	0.00181	CcSEcCtD
Sotalol—Dyspnoea—Epirubicin—liver cancer	0.00179	0.0018	CcSEcCtD
Sotalol—Somnolence—Epirubicin—liver cancer	0.00178	0.0018	CcSEcCtD
Sotalol—Dyspepsia—Epirubicin—liver cancer	0.00177	0.00178	CcSEcCtD
Sotalol—Decreased appetite—Epirubicin—liver cancer	0.00175	0.00176	CcSEcCtD
Sotalol—Hypotension—Doxorubicin—liver cancer	0.00174	0.00175	CcSEcCtD
Sotalol—Fatigue—Epirubicin—liver cancer	0.00173	0.00174	CcSEcCtD
Sotalol—Pain—Epirubicin—liver cancer	0.00172	0.00173	CcSEcCtD
Sotalol—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00169	0.00171	CcSEcCtD
Sotalol—Insomnia—Doxorubicin—liver cancer	0.00168	0.00169	CcSEcCtD
Sotalol—Paraesthesia—Doxorubicin—liver cancer	0.00167	0.00168	CcSEcCtD
Sotalol—Dyspnoea—Doxorubicin—liver cancer	0.00166	0.00167	CcSEcCtD
Sotalol—Somnolence—Doxorubicin—liver cancer	0.00165	0.00166	CcSEcCtD
Sotalol—Gastrointestinal pain—Epirubicin—liver cancer	0.00164	0.00165	CcSEcCtD
Sotalol—Dyspepsia—Doxorubicin—liver cancer	0.00164	0.00165	CcSEcCtD
Sotalol—Decreased appetite—Doxorubicin—liver cancer	0.00161	0.00163	CcSEcCtD
Sotalol—Fatigue—Doxorubicin—liver cancer	0.0016	0.00161	CcSEcCtD
Sotalol—Pain—Doxorubicin—liver cancer	0.00159	0.0016	CcSEcCtD
Sotalol—Abdominal pain—Epirubicin—liver cancer	0.00159	0.0016	CcSEcCtD
Sotalol—Body temperature increased—Epirubicin—liver cancer	0.00159	0.0016	CcSEcCtD
Sotalol—Gastrointestinal pain—Doxorubicin—liver cancer	0.00152	0.00153	CcSEcCtD
Sotalol—Abdominal pain—Doxorubicin—liver cancer	0.00147	0.00148	CcSEcCtD
Sotalol—Body temperature increased—Doxorubicin—liver cancer	0.00147	0.00148	CcSEcCtD
Sotalol—Asthenia—Epirubicin—liver cancer	0.00144	0.00145	CcSEcCtD
Sotalol—Pruritus—Epirubicin—liver cancer	0.00142	0.00143	CcSEcCtD
Sotalol—Diarrhoea—Epirubicin—liver cancer	0.00137	0.00138	CcSEcCtD
Sotalol—Asthenia—Doxorubicin—liver cancer	0.00133	0.00134	CcSEcCtD
Sotalol—Dizziness—Epirubicin—liver cancer	0.00133	0.00134	CcSEcCtD
Sotalol—Pruritus—Doxorubicin—liver cancer	0.00131	0.00132	CcSEcCtD
Sotalol—Vomiting—Epirubicin—liver cancer	0.00128	0.00129	CcSEcCtD
Sotalol—Diarrhoea—Doxorubicin—liver cancer	0.00127	0.00128	CcSEcCtD
Sotalol—Rash—Epirubicin—liver cancer	0.00127	0.00128	CcSEcCtD
Sotalol—Dermatitis—Epirubicin—liver cancer	0.00126	0.00127	CcSEcCtD
Sotalol—Ibuprofen—ALB—liver cancer	0.00126	0.17	CrCbGaD
Sotalol—Headache—Epirubicin—liver cancer	0.00126	0.00127	CcSEcCtD
Sotalol—Dizziness—Doxorubicin—liver cancer	0.00123	0.00124	CcSEcCtD
Sotalol—Nausea—Epirubicin—liver cancer	0.00119	0.0012	CcSEcCtD
Sotalol—Vomiting—Doxorubicin—liver cancer	0.00118	0.00119	CcSEcCtD
Sotalol—Rash—Doxorubicin—liver cancer	0.00117	0.00118	CcSEcCtD
Sotalol—Dermatitis—Doxorubicin—liver cancer	0.00117	0.00118	CcSEcCtD
Sotalol—Headache—Doxorubicin—liver cancer	0.00116	0.00117	CcSEcCtD
Sotalol—Nausea—Doxorubicin—liver cancer	0.0011	0.00111	CcSEcCtD
